Syros Pharmaceuticals Reports Third Quarter 2016 Financial Results and Provides Business Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/18/2026

1. XENE
2. SPY
3. HUBS
4. NUE
5. AAPL
6. ONON
7. AZN
8. TRMD
9. NVDA
10. RARE

Go back to Syros Pharmaceuticals Reports Third Quarter 2016 Financial Results and Provides Business Update

Syros Pharmaceuticals (SYRS) Misses Q3 EPS by 11c

November 14, 2016 8:09 AM EST

Syros Pharmaceuticals (NASDAQ: SYRS) reported Q3 EPS of ($0.65), $0.11 worse than the analyst estimate of ($0.54).

Cash and cash equivalents as of September 30, 2016 were $93.5 million, compared with $35.9 million on December 31, 2015. The increase in cash includes the net proceeds from the Companys IPO that... More